Search

everythinglearnresearchcommunity

for

Search:↓

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Treatment during development affects hormone balance and sexual behavior in male rats.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Most patients improved with oral contraceptives, but some needed additional treatment.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Eating disorders can cause various hair problems, and while hair loss in these disorders is linked to metabolic syndrome, treatment focuses on specific medications and lifestyle changes for the syndrome.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.